![]() |
市场调查报告书
商品编码
1831883
2025-2033年手术缝线市场报告(按类型、材料、应用、最终用户和地区)Surgical Sutures Market Report by Type, Material, Application, End User, and Region 2025-2033 |
2024年,全球手术缝线市场规模达54亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到86亿美元,2025-2033年期间的复合年增长率(CAGR)为5.06%。先进缝合材料的开发、技术的快速进步、消费者对微创手术(MIS)的偏好转变、消费者人均收入的增加以及整容手术的蓬勃发展,都是推动市场成长的一些因素。
慢性病盛行率不断上升
在全球范围内,慢性病的发生率正以前所未有的速度增长,这进一步刺激了对手术缝线的需求。根据世界卫生组织 (WHO) 统计,每年约有 4,100 万人死于非传染性疾病,占全球死亡人数的 74%。肥胖、糖尿病、心血管疾病和癌症的盛行率不断上升,导致对外科手术的需求激增,进一步刺激了市场成长。根据国际糖尿病联盟 (IDF) 的数据,到 2045 年,将有约 7.83 亿人患有糖尿病。由于人口老化和生活方式改变等因素,这些疾病变得越来越普遍,对外科手术的需求也不断增加。因此,对手术缝合线的需求也越来越大,因为手术缝合线对于术后伤口的缝合至关重要。
先进缝合材料的开发
外科缝合线市场的最新发展彻底改变了伤口闭合技术,进一步支撑了市场成长。主要市场参与者正在开发与人体更相容的现代缝合线,以最大限度地降低感染风险并促进快速癒合。例如,2023年5月,来自麻省理工学院(MIT)的一支工程师团队开发了「智慧」缝合线,预计将接受手术的克罗恩病患者受益,并可用于药物输送、发炎感知和细胞疗法。这些进步有助于改善患者的治疗效果,并满足外科医生不断变化的需求,标誌着外科护理领域的重大飞跃。
整容手术日益盛行
消费者人均收入的不断增长,大幅提升了人们对美容的需求,进一步刺激了对整容手术的需求,而整容手术是推动市场成长的主要因素。根据国际美容整形外科学会 (ISAPS) 2020 年的数据,2019 年全球共进行了超过 2,400 万例非手术和手术美容手术。美容手术对精准度要求极高,这进一步催生了对高品质缝合材料的需求,以达到最佳的美容效果并确保最小的疤痕。在社会压力、媒体影响和自我提升慾望的推动下,蓬勃发展的美容产业导致外科手术数量激增。
可吸收缝合线占据大部分市场份额
可吸收缝合线细分市场的发展动力源于微创外科手术需求的不断增长,以及人们对可吸收材料的日益青睐,因为可吸收材料能够随着时间的推移在体内无害地分解,无需拆线。此外,技术进步推动了抗拉强度、柔韧性和生物相容性增强的可吸收缝合线的开发,进一步推动了该细分市场的成长。例如,2023年5月,一种新型奈米复合涂层被开发出来,它可以抑制生物膜的形成并杀死附着的细菌,进一步应对因细菌抗药性而导致的术后感染病例激增。根据世界卫生组织的数据,术后手术部位感染 (SSI) 影响中低收入国家约11%的患者。它们是由切口部位或切口内软组织中生物膜的形成引起的。此外,慢性疾病和手术发病率的不断上升,加上全球老年人口的不断增长,正在推动市场的成长。
复丝占业界最大份额
外科缝合线市场中,对柔韧性和操作性更强的缝合线的需求日益增长,尤其是在需要精确打结的精细外科手术中,这推动了多丝缝合线市场的发展。此外,製造技术的进步使得生产出抗拉强度更高、组织创伤更小的多丝缝合线成为可能,从而促进了其在外科医生中的应用。此外,全球慢性病的日益流行和外科手术数量的不断增加,也推动了对多丝缝合线的需求,因为与单丝缝合线相比,多丝缝合线能够更好地闭合伤口并降低感染风险。此外,由于人们越来越关注患者的舒适度和更快的术后恢復,XYZ 缝合线市场也正在经历成长,因为多丝缝合线通常可以减少组织反应和炎症,从而改善癒合效果。
心血管手术是领先的细分市场
全球心血管疾病的发生率不断上升,推动了外科缝线市场中心血管手术细分市场的发展,这需要增加外科手术干预措施来应对这些疾病。根据 iData Research 的数据,美国每年约有 90 万例心血管手术,预计到 2029 年将达到 130 万例。随着人口老化加剧以及不健康饮食和久坐不动等生活方式因素导致心血管疾病激增,对有效缝合材料的需求也日益增加,以确保最佳的伤口闭合和患者的康復。此外,包括微创手术在内的外科技术的进步,也推动了对专用缝合线的需求,这些缝合线旨在承受心血管手术特有的挑战,例如缝合线的高张力和持续压力。
医院和诊所在市场上占据明显主导地位
医院业务板块的驱动力来自于全球外科手术数量的增长,这主要源于肥胖症和其他慢性疾病患病率的上升、人口老化以及医疗基础设施的不断扩张。世界卫生组织的数据显示,超过43%的18岁以上成年人超重,16%患有肥胖症。医院需要具有优异抗拉强度、打结安全性和生物相容性的外科缝合线,以确保最佳的伤口闭合效果并最大限度地减少术后併发症。此外,随着外科技术的进步和微创手术的普及,需要能够精确缝合组织并促进更快恢復的专用缝线。根据美国国家医学图书馆的数据,2017年共进行了约980万例住院手术,其中约11.1%为微创手术,2.5%为机器人辅助手术。
北美引领市场,占据最大的手术缝合线市场份额
该报告还对所有主要区域市场进行了全面分析,包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告指出,北美是最大的外科缝线区域市场。
北美外科缝合线市场的成长得益于医疗保健支出的快速成长、主要市场参与者的加入以及事故数量的上升。美国和加拿大的存在也为该地区提供了支持。美国拥有多家领先的外科缝线公司,如史赛克公司、美敦力公司、波士顿科学公司、爱惜康公司、捷迈邦美控股公司、泰利福公司等。根据美国医院协会 (AHA) 的数据,美国约有 6,090 家医院。业内消息人士也显示,美国每年估计进行 4,830 万例非手术和手术。除了结肠和肠道切除术之外,皮肤肿瘤切除、胆囊和胆道治疗、疝气修补术是一般外科医生最常进行的外科手术。
The global surgical sutures market size reached USD 5.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.06% during 2025-2033. Development of advanced suture materials, rapid technological advancements, shifting consumer preference towards minimally invasive surgeries (MIS), inflating consumer per capita income, and burgeoning prevalence of cosmetic surgeries are some of the factors bolstering the market growth.
Escalating chronic diseases prevalence
Globally, the prevalence of chronic diseases in increasing at an unprecedented rate, which has further burgeoned the demand for surgical sutures. As pe the World Health Organization (WHO), about 41 million people die of non-communicable diseases every year, which is equivalent to 74% of all the deaths globally. The escalating prevalence of obesity, diabetes, cardiovascular ailments, and cancers have surged the requirement for surgical interventions, which is further stimulating the market growth. As per the International Diabetes Federation (IDF), by 2045, about 783 million people will be living with diabetes. As these conditions become more common due to factors like aging populations and lifestyle changes, the demand for surgical procedures escalates. Consequently, there's a heightened need for surgical sutures, essential for closing wounds post-surgery.
Development of advanced suture materials
Recent developments in the surgical sutures market have completely changed the wound closure techniques, which is further supporting the market growth. Key market players are developing modern sutures that are more compatible with the human body in order to minimize the risk of infection and promote fast healing. For instance, in May 2023, a team of engineers from the Massachusetts Institute of Technology (MIT) developed "smart" sutures with the potential to benefit Crohn's disease patients undergoing surgery, and could also have applications for drug delivery, sensing inflammation, and cell therapies. These advancements help to improve patient outcomes and also cater to the evolving needs of surgeons, marking a significant leap forward in surgical care.
Burgeoning prevalence of cosmetic surgeries
The inflating consumer per capita income has considerably surged the need to seek aesthetic enhancements, further boosting the demand for cosmetic surgeries, which represents the primary factor propelling the market growth. As per the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, over 24 million non-surgical and surgical aesthetic procedures were performed globally in 2019. Aesthetic procedures require most precision, which has further burgeoned the requirement for high-quality suture materials to optimal aesthetic outcomes and ensure minimal scarring. The burgeoning cosmetic industry, fueled by societal pressures, media influence, and the desire for self-improvement, has led to a surge in surgical interventions.
Absorbable sutures accounts for the majority of the market share
The absorbable sutures segment is driven by the increasing demand for minimally invasive surgical procedures and the rising preference for absorbable materials due to their ability to break down harmlessly in the body over time, eliminating the need for suture removal. Additionally, advancements in technology leading to the development of absorbable sutures with enhanced tensile strength, flexibility, and biocompatibility further fuel the growth of this segment. For instance, in May 2023, a new nanocomposite coating was developed that can inhibit biofilm formation and also kill attached bacteria, further tackling the surging cases of post-operative infections, caused due to antibiotic resistance in bacteria. As per the WHO, post-operative surgical site infections (SSIs) affect about 11% of patients in low and middle-income countries. They are caused due to the development of biofilms on the incision site or in the soft tissue inside the site. Moreover, the growing incidence of chronic diseases and surgeries, coupled with the expanding geriatric population globally, are propelling the market growth.
Multifilament holds the largest share of the industry
The multifilament segment in the surgical sutures market is driven by the increasing demand for sutures with enhanced flexibility and handling characteristics, particularly in delicate surgical procedures where precise knot tying is essential. Additionally, advancements in manufacturing technologies have allowed for the production of multifilament sutures with improved tensile strength and reduced tissue trauma, thereby boosting their adoption among surgeons. Moreover, the growing prevalence of chronic diseases and the rising number of surgical procedures worldwide are propelling the demand for multifilament sutures, as they offer better wound closure and reduced risk of infection compared to monofilament alternatives. Furthermore, the XYZ segment is witnessing growth due to the escalating focus on patient comfort and faster postoperative recovery, as multifilament sutures are often associated with reduced tissue reaction and inflammation, leading to improved healing outcomes.
Cardiovascular Surgeries represents the leading market segment
The cardiovascular surgeries segment in the surgical sutures market is driven by the increasing prevalence of cardiovascular diseases globally, necessitating a rise in surgical interventions to address these conditions. As per the iData Research, about 900,000 cardiovascular procedures were carried out each year in the United States, and the number is projected to reach 1.3 million by 2029. With the growing aging population and lifestyle factors such as unhealthy diets and sedentary lifestyles contributing to the surge in cardiovascular issues, there's a heightened demand for effective suturing materials to ensure optimal wound closure and patient recovery. Additionally, advancements in surgical techniques, including minimally invasive procedures, are fueling the demand for specialized sutures designed to withstand the unique challenges of cardiovascular surgeries, such as high tension and continuous stress on the sutures.
Hospitals and clinics exhibits a clear dominance in the market
The hospitals segment is driven by the increasing volume of surgical procedures performed globally, spurred by rising prevalence of obesity and other chronic diseases, aging population, and expanding healthcare infrastructure. As per the WHO, over 43% of adults aged 18 and above were overweight and 16% were living with obesity. Hospitals demand surgical sutures characterized by superior tensile strength, knot security, and biocompatibility to ensure optimal wound closure and minimize post-operative complications. Moreover, advancements in surgical techniques and the adoption of minimally invasive procedures necessitate specialized sutures that enable precise tissue approximation and facilitate faster recovery. As per the National Library of Medicine, in 2017 about 9.8 million inpatient operating room procedures were conducted, from which about 11.1% of these procedures were minimally invasive and 2.5% were robotic-assisted.
North America leads the market, accounting for the largest surgical sutures market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical sutures.
The North America surgical sutures market growth is driven by the burgeoning healthcare expenditure, presence of key market players, and the rising cases of accidents. The region is also backed by the presence of the United States and Canada. The United States has a robust presence of several leading surgical suture companies, such as Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Ethicon Inc, Zimmer Biomet Holdings Inc, Teleflex Incorporated, and others. As per the American Hospital Association (AHA), the country has around 6,090 hospitals. Industry sources also show that every year, an estimated 48.3 million non-surgical and surgical procedures are performed in the United States. Skin tumor excision, gallbladder and biliary tree treatments, and hernia repairs, in addition to colon and intestine resections, are some of the most common surgical procedures performed by general surgeons.